Shanghai WiseGain Medical Devices Co., Ltd.
Quick facts
Phase 3 pipeline
- Amlodipine, losartan potassium and hydrochlorothiazide · Cardiovascular
This triple-combination antihypertensive reduces blood pressure through three complementary mechanisms: calcium channel blockade, angiotensin II receptor antagonism, and thiazide diuresis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: